Venture Capital Roundtable (3/3): What investors may be underestimating in 2026
What might investors be overlooking as they look ahead to 2026? From biotech shifts to climate resilience and distribution, our panel explores the themes that could shape future outcomes in part 3 of the venture capital roundtable series.
This is premium content
You are not logged in, Sign in or register to request access. Please note: If you had prior access to this content you may need to sign in again.
Asset Owners
If you are an institutional investor you are eligable for free access to all premium content.